Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Steegmann

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|January 1, 1991
Interferon alpha treatment of accelerated-phase chronic myeloid leukemia in relapse after bone marrow transplantation: a case with complete cytogenetic and molecular remissionJ L Steegmann, M Pérez, L Vázquez, et al.
American Journal of Hematology|November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)J L Steegmann, M J Requena, L F Casado, et al.
Bone Marrow Transplantation|December 1, 1992
Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trialJ L Steegmann, J López, M J Otero, et al.
Revista Clinica Espanola|April 11, 2016
Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registryS Osorio, L F Casado, P Giraldo, et al.
Sangre|July 10, 1998
[Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives]J L Steegmann, E Granados, F Rodríguez-Salvanés, et al.
American Journal of Hematology|March 1, 1994
Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplantJ López, J L Steegmann, G Pérez, et al.
Bone Marrow Transplantation|June 1, 1992
Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia. Results from a single institutionR De la Cámara, A Figuera, J L Steegmann, et al.
Bone Marrow Transplantation|September 1, 1992
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre studyJ López, L Vázquez, F Serrano, et al.
Seminars in Hematology|February 4, 2003
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapyJ Hasford, M Pfirrmann, R Hehlmann, et al.
Sangre|December 30, 1998
[Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2]J L Steegmann, E Granados, L Vázquez, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|January 1, 1991
Interferon alpha treatment of accelerated-phase chronic myeloid leukemia in relapse after bone marrow transplantation: a case with complete cytogenetic and molecular remissionJ L Steegmann, M Pérez, L Vázquez, et al.
American Journal of Hematology|November 1, 1996
Southern technique and cytogenetics are complementary and must be used together in the evaluation of Ph1, M-BCR positive chronic myeloid leukemia (CML) patients treated with alpha interferon (IFN-alpha)J L Steegmann, M J Requena, L F Casado, et al.
Bone Marrow Transplantation|December 1, 1992
Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trialJ L Steegmann, J López, M J Otero, et al.
Revista Clinica Espanola|April 11, 2016
Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registryS Osorio, L F Casado, P Giraldo, et al.
Sangre|July 10, 1998
[Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives]J L Steegmann, E Granados, F Rodríguez-Salvanés, et al.
American Journal of Hematology|March 1, 1994
Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplantJ López, J L Steegmann, G Pérez, et al.
Bone Marrow Transplantation|June 1, 1992
Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia. Results from a single institutionR De la Cámara, A Figuera, J L Steegmann, et al.
Bone Marrow Transplantation|September 1, 1992
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre studyJ López, L Vázquez, F Serrano, et al.
Seminars in Hematology|February 4, 2003
Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapyJ Hasford, M Pfirrmann, R Hehlmann, et al.
Sangre|December 30, 1998
[Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2]J L Steegmann, E Granados, L Vázquez, et al.
Pageof 7